Alnylam Widens Vaccine IP Litigation Against Pfizer, Moderna
Shortly after obtaining additional patents on vaccine delivery technology from the U.S. Patent and Trademark Office, pharmaceutical company Alnylam has expanded its infringement litigation against Pfizer and Moderna over their COVID-19...To view the full article, register now.
Already a subscriber? Click here to view full article